European Journal of Cancer
Volume 45, Issue 7 , Pages 1209-1217 , May 2009

Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT‘91

  • Katja von Hoff

      Affiliations

    • Department of Pediatrics, University of Wuerzburg, Germany
    • ,
  • Bernward Hinkes

      Affiliations

    • Department of Pediatrics, University of Wuerzburg, Germany
    • ,
  • Nicolas U. Gerber

      Affiliations

    • Department of Pediatrics, University of Wuerzburg, Germany
    • ,
  • Frank Deinlein

      Affiliations

    • Department of Pediatrics, University of Wuerzburg, Germany
    • ,
  • Uwe Mittler

      Affiliations

    • University Children’s Hospital of Magdeburg, Germany
    • ,
  • Christian Urban

      Affiliations

    • Division of Paediatric Haematology and Oncology, Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Austria
    • ,
  • Martin Benesch

      Affiliations

    • Division of Paediatric Haematology and Oncology, Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Austria
    • ,
  • Monika Warmuth-Metz

      Affiliations

    • Department of Neuroradiology, University of Wuerzburg, Germany
    • ,
  • Niels Soerensen

      Affiliations

    • Department of Neurosurgery, ev. Hospital Oldenburg, Germany
    • ,
  • Isabella Zwiener

      Affiliations

    • Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University of Mainz, Germany
    • ,
  • Heiko Goette

      Affiliations

    • Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University of Mainz, Germany
    • ,
  • Paul G. Schlegel

      Affiliations

    • Department of Pediatrics, University of Wuerzburg, Germany
    • ,
  • Torsten Pietsch

      Affiliations

    • Department of Neuropathology, University of Bonn, Germany
    • ,
  • Rolf D. Kortmann

      Affiliations

    • Department of Radiation Oncology, University of Leipzig, Germany
    • ,
  • Joachim Kuehl

      Affiliations

    • Department of Pediatrics, University of Wuerzburg, Germany
    • ,
  • Stefan Rutkowski

      Affiliations

    • Department of Pediatrics, University of Wuerzburg, Germany
    • University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hamburg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 40 7410 54270; fax: +49 40 7410 54601.

Received 24 November 2008 ,Accepted 15 January 2009.

References 

  1. Kaatsch P, Rickert CH, Kuhl J, Schuz J, Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer. 2001;92(12):3155–3164
  2. Tait DM, Thornton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer. 1990;26(4):464–469
  3. Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg. 1990;72(4):572–582
  4. Bailey CC, Gnekow A, Wellek S, Jones M, Round C, Brown J, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol. 1995;25(3):166–178
  5. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24(25):4202–4208
  6. Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7(10):813–820
  7. Verlooy J, Mosseri V, Bracard S, Tubiana AL, Kalifa C, Pichon F, et al. Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study. Eur J Cancer. 2006;42(17):3004–3014
  8. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol. 1999;17(3):832–845
  9. Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, et al. Outcome for patients with metastatic (M2–3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer. 2005;41(5):727–734
  10. Kortmann RD, Kuhl J, Timmermann B, Mittler U, Urban C, Budach V, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT‘91. Int J Radiat Oncol Biol Phys. 2000;46(2):269–279
  11. Chang CH, Housepian EM, Herbert C. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology. 1969;93(6):1351–1359
  12. Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children’s Cancer Study Group PNET-3 study. J Clin Oncol. 2003;21(8):1581–1591
  13. Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a children’s cancer group study. J Clin Oncol. 1999;17(7):2127–2136
  14. Morris EB, Gajjar A, Okuma JO, Yasui Y, Wallace D, Kun LE, et al. Survival and late mortality in long-term survivors of pediatric CNS tumors. J Clin Oncol. 2007;25(12):1532–1538
  15. Timmermann B, Kortmann RD, Kuhl J, Meisner C, Slavc I, Pietsch T, et al. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys. 2000;46(2):287–295
  16. Wolff JE, Gnekow AK, Kortmann RD, Pietsch T, Urban C, Graf N, et al. Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer. 2002;94(1):264–271
  17. Kortmann RD, Timmermann B, Kuhl J, Willich N, Flentje M, Meisner C, et al. HIT‘91 (prospective, co-operative study for the treatment of malignant brain tumors in childhood): accuracy and acute toxicity of the irradiation of the craniospinal axis. Results of the quality assurance program. Strahlenther Onkol. 1999;175(4):162–169
  18. Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, et al. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg. 1991;74(3):433–440
  19. Oyharcabal-Bourden V, Kalifa C, Gentet JC, Frappaz D, Edan C, Chastagner P, et al. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French society of pediatric oncology study. J Clin Oncol. 2005;23(21):4726–4734
  20. Carrie C, Muracciole X, Gomez F, Habrand JL, Benhassel M, Mege M, et al. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys. 2005;63(3):711–716
  21. Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg. 1994;81(5):690–698
  22. Gajjar A, Sanford RA, Bhargava R, Heideman R, Walter A, Li Y, et al. Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome. Pediatr Neurosurg. 1996;25(4):182–187
  23. Merchant TE, Wang MH, Haida T, Lindsley KL, Finlay J, Dunkel IJ, et al. Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era. Int J Radiat Oncol Biol Phys. 1996;36(1):29–35
  24. Miralbell R, Bieri S, Huguenin P, Feldges A, Morin AM, Garcia E, et al. Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma. Swiss pediatric oncology group. Ann Oncol. 1999;10(2):239–241
  25. Sanders RP, Onar A, Boyett JM, Broniscer A, Morris EB, Qaddoumi I, et al. M1 medulloblastoma: high risk at any age. J Neurooncol. 2008;
  26. Rutkowski S, von Bueren A, von Hoff K, Hartmann W, Shalaby T, Deinlein F, et al. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT‘91. Clin Cancer Res. 2007;13(9):2651–2657
  27. Yock T, Friedman H, Kun L, Kepner J, Barnes P, Tarbell N. Response to pre-radiation chemotherapy is predictive of improved survival in high risk medulloblastoma: results from pediatric oncology group (POG 9031). Int J Radiat Oncol Biol Phys. 2001;51(3):120–121
  28. Lefkowitz IB, Packer RJ, Ryan SG, Shah N, Alavi J, Rorke LB, et al. Late recurrence of primitive neuroectodermal tumor/medulloblastoma. Cancer. 1988;62(4):826–830
  29. Stavrou T, Bromley CM, Nicholson HS, Byrne J, Packer RJ, Goldstein AM, et al. Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol. 2001;23(7):431–436
  30. Broniscer A, Ke W, Fuller CE, Wu J, Gajjar A, Kun LE. Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude children’s research hospital experience. Cancer. 2004;100(10):2246–2252
  31. Goldstein AM, Yuen J, Tucker MA. Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control. 1997;8(6):865–871

PII: S0959-8049(09)00022-7

doi: 10.1016/j.ejca.2009.01.015

European Journal of Cancer
Volume 45, Issue 7 , Pages 1209-1217 , May 2009

Article Tools

* Image Usage & Resolution